Nuvectis Pharma (NVCT) Earnings Date, Estimates & Call Transcripts → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free NVCT Stock Alerts $6.77 +0.42 (+6.61%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (Mar. 5) -$0.41 Missed By -$0.01 Consensus EPS (Mar. 5) -$0.40 Get Nuvectis Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVCT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVCT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Nuvectis Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.41)($0.39)($0.40)Q2 20242($0.29)($0.23)($0.26)Q3 20242($0.38)($0.24)($0.31)Q4 20242($0.39)($0.24)($0.32)FY 20248($1.47)($1.10)($1.29)NVCT Earnings Date and InformationNuvectis Pharma last released its quarterly earnings results on March 5th, 2024. The reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.01. Nuvectis Pharma has generated ($1.41) earnings per share over the last year (($1.41) diluted earnings per share). Earnings for Nuvectis Pharma are expected to decrease in the coming year, from ($1.29) to ($1.41) per share. Nuvectis Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More Nuvectis Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 3/5/2024Q4 2023($0.40)($0.41)($0.01)($0.41)--11/8/2023Q3 2023($0.38)($0.37)+$0.01($0.37)--8/9/2023Q2 2023($0.34)($0.38)($0.04)($0.38)--5/10/2023Q1 2023($0.44)($0.27)+$0.17($0.27)--3/7/2023Q4 2022($0.36)($0.48)($0.12)($0.48)--11/8/2022Q3 2022($0.27)($0.42)($0.15)($0.42)-- Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/5/2022Q2 2022($0.24)($0.28)($0.04)($0.28)--5/10/2022Q1 2022($0.23)($0.32)($0.09)($0.32)-- Nuvectis Pharma Earnings - Frequently Asked Questions When is Nuvectis Pharma's earnings date? Nuvectis Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on NVCT's earnings history. Did Nuvectis Pharma beat their earnings estimates last quarter? In the previous quarter, Nuvectis Pharma (NASDAQ:NVCT) missed the analysts' consensus estimate of ($0.40) by $0.01 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. NVCT's actual earnings. How much profit does Nuvectis Pharma generate each year? Nuvectis Pharma (NASDAQ:NVCT) has a recorded net income of -$22.26 million. NVCT has generated -$1.41 earnings per share over the last four quarters. What is Nuvectis Pharma's EPS forecast for next year? Nuvectis Pharma's earnings are expected to decrease from ($1.29) per share to ($1.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies: VTGN Earnings Results AMLX Earnings Results DMAC Earnings Results OPTN Earnings Results COYA Earnings Results CNTX Earnings Results KPTI Earnings Results PDSB Earnings Results FGEN Earnings Results RNAC Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:NVCT) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersBiden to Drop BOMBSHELL June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.